The inflammatory adipocytokines (leptin, CCL2, IL-1β, and resistin) secreted by adipocytes and FFAs released by MDA-MB-231 cells confer acquired doxorubicin resistance in BC by generating inflammation and lipid metabolic reprogramming in the TME61. Here, CCL2 is linked to breast cancer.